Formulation Studies to Develop Low-Cost, Orally-Delivered Secretory IgA Monoclonal Antibodies for Passive Immunization Against Enterotoxigenic Escherichia coli.
J Pharm Sci
; 112(7): 1832-1844, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37040833
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Escherichia coli Infections
/
Enterotoxigenic Escherichia coli
Type of study:
Health_economic_evaluation
Limits:
Child
/
Humans
Language:
En
Journal:
J Pharm Sci
Year:
2023
Type:
Article
Affiliation country:
United States